Abstracts Archive - Page 242 of 1683 - ATC Abstracts

2021 American Transplant Congress
Impact of Electronic Donor Referral Technology on Deceased Donor Referrals
B. Boyarsky¹, J. R. DiRito², K. Vanterpool¹, J. Piano³, W. Liu³, J. Hewlett⁴, C. Trahan⁴, D. Segev¹, M. Levan¹, A. Massie¹, P. Niles⁴
¹Johns Hopkins, Baltimore, MD, ²Yale, New Haven, CT, ³Transplant Connect, Santa Monica, CA, ⁴Southwest Transplant Alliance, Dallas, TX
*Purpose: Hospitals likely fail to refer many medically eligible potential deceased donors to OPOs. As such, increasing eligible referrals may increase the donor pool. We…
2021 American Transplant Congress
Trends of Kidney Transplant Volume During Covid-19 Era
G. Rajashekar¹, S. Chang¹, K. Lentine², J. Wellen¹, T. Alhamad¹, M. Merzkani¹, H. Murad¹
¹Nephrology, Washington University in St. Louis, Saint louis, MO, ²Nephrology, SSM Saint Louis University, Saint louis, MO
*Purpose: The emergence of SARS-CoV-2 and the clinical syndrome of COVID-19 have significantly disrupted routine healthcare and life-saving procedures, including solid organ transplantation. This resulted…
2021 American Transplant Congress
Higher Calcineurin Inhibitor Levels Associate with Graft Outcomes in Kidney Recipients with De Novo Donor-specific Antibodies of Either Hla Class I or II
M. Béland, S. De Serres
Nephrology, CHU de Québec- Université Laval, Québec, QC, Canada
*Purpose: The development of de novo anti-HLA donor specific antibodies (dnDSA) is associated with poorer outcomes in kidney transplant recipients. We and other previously reported…
2021 American Transplant Congress
Controlled Donation After Circulatory Death Pancreas Transplantation in Spain. Initial Experience
J. Ferrer-Fàbrega¹, R. Muñoz², J. Ruiz³, D. Casanova⁴, F. Sánchez-Bueno⁵, J. Pérez-Daga⁶, C. Fernández-Rivera⁷, M. Gómez⁸, F. Castillo⁹, R. López-Andújar¹⁰, J. Maupoey¹⁰, J. Briceño¹¹, J. Sánchez-Hidalgo¹¹, Á. Arjona¹¹, A. Álvarez¹², A. Alarcó¹³, A. Bravo¹³, R. García¹, R. Rull¹, M. López-Boado¹, P. Ventura-Aguiar¹⁴, F. Diekmann¹⁴, D. Paredes¹⁵, J. García-Valdecasas¹, J. Fuster¹, C. Fondevila¹, B. Domínguez-Gil²
¹Hepatobiliopancreatic Surgery and Transplantation Department, Hospital Clínic Barcelona, Barcelona, Spain, ²Organización Nacional de Trasplantes (ONT), Madrid, Spain, ³Department of Nephrology., University Hospital Marques de Valdecilla. University Cantabria, Santander., Santander, Spain, ⁴Department of Surgery, University Hospital Marques de Valdecilla, University Cantabria, Santander., Santander, Spain, ⁵Department of General, Visceral and Transplantation Surgery., Clinic and University Hospital Virgen de la Arrixaca. IMIB-ARRIXACA. Murcia., Murcia, Spain, ⁶Department of Surgery, Hospital Regional de Málaga. Málaga., Málaga, Spain, ⁷Department of Nephrology., Complexo Hospitalario Universitario de A Coruña. A Coruña, A Coruña, Spain, ⁸Department of Surgery, Complexo Hospitalario Universitario de A Coruña. A Coruña, A Coruña, Spain, ⁹Department of Surgery, University Hospital Marques de Valdecilla. University Cantabria, Santander., Santander, Spain, ¹⁰Hepato-Pancreatico-Biliary Surgery and Transplant Unit, La Fe University Hospital. Valencia, Valencia, Spain, ¹¹Department of Surgery, Hospital Universitario Reina Sofía. Córdoba, Córdoba, Spain, ¹²Department of Nephrology., Hospital Universitario de Canarias. Tenerife., Tenerife, Spain, ¹³Department of Surgery, Hospital Universitario de Canarias. Tenerife., Tenerife, Spain, ¹⁴Renal Transplant Unit, Hospital Clínic Barcelona, Barcelona, Spain, ¹⁵Coordination Department, Hospital Clínic Barcelona, Barcelona, Spain
*Purpose: To report on the Spanish Pancreas Transplantation experience in controlled donation after circulatory death (cDCD) by analyzing the normothermic regional perfusion (NRP) and super-rapid…
2021 American Transplant Congress
Risk Factors and Outcome of Transplant Renal Artery Stenosis in Kidney Transplant Recipients – A Nested Case-control Study
D. Choudhary¹, A. Sharma¹, R. Vijayvergiya², G. Kasinadhuni², D. Kenwar¹, S. Singh¹
¹Renal & Pancreas Transplant Surgery, Pgimer Chandigarh, Chandigarh, India, ²Cardiology, Pgimer Chandigarh, Chandigarh, India
*Purpose: Transplant renal artery stenosis (TRAS) is a treatable cause of renal allograft dysfunction. It presents commonly in the early post-transplant period with variable clinical…
2021 American Transplant Congress
Dual Liver and Kidney Donors, What Makes Them Decide to Do It?
H. Al Harakeh, B. Emmanuel, C. Hughes, A. Tevar, J. Steel, A. F. DiMartini, S. Ganesh, A. Humar
Surgery, University of Pittsburgh Medical Center, Pittsburgh, PA
*Purpose: There is incongruity between the transplant waiting list and the number of deceased donors available, therefore there is an enduring challenge to increase the…
2021 American Transplant Congress
Kidney Transplant Biopsy Findings After Covid-19
E. Daniel¹, S. Kudose², D. J. Cohen¹, L. Ratner³, V. D'Agati², I. Batal²
¹Division of Nephrology, Columbia University Medical Center, NY, NY, ²Department of Pathology, Columbia University Medical Center, NY, NY, ³Department of Surgery, Columbia University Medical Center, NY, NY
*Purpose: COVID-19 has been reported as a cause of kidney injury and data from published native kidney biopsy results demonstrate a variety of causes. To…
2021 American Transplant Congress
Engineered Human Glomerular Endothelial Cells to Identify Non-hla Antibodies and Decipher Their Pathogenicity After Kidney Transplantation
B. Lamarthée¹, C. Burger¹, C. Leclaire¹, L. Morin¹, F. Terzi¹, C. Tinel¹, D. Anglicheau²
¹Inserm U1151, Necker-Enfants Malades Institute, PARIS, France, ²Necker Hospital, AP-HP, Department of Nephrology and Kidney Transplantation, PARIS, France
*Purpose: In kidney transplantation recipients (KTRs), donor-specific antibodies directed against Human Leucocyte Antigens (HLA-DSA) are thought to drive antibody-mediated rejection (AMR) and poor transplant outcome.…
2021 American Transplant Congress
Donor Derived Transmissions 2019: Analysis of the OPTN Ad Hoc Disease Transmission Advisory Committee (DTAC)
L. Danziger-Isakov¹, M. G. Michaels¹, A. Agarwal¹, S. Aslam¹, K. Dunn¹, J. Goldman¹, D. Levine¹, C. Marboe¹, G. Marklin¹, S. Pouch¹, M. Rana¹, R. Razonable¹, H. L. Stevenson¹, H. S. Te¹, A. Woolley¹, E. Ward², C. Jett², L. Cartwright², R. La Hoz¹
¹OPTN DTAC, Richmond, VA, ²UNOS, Richmond, VA
*Purpose: The OPTN DTAC, a multidisciplinary group, evaluates potential donor derived transmission events (PDDTE), mostly infections (I) & malignancies (M), to assess the likelihood of…
2021 American Transplant Congress
A Noninvasive Diagnostic Approach for Molecular Monitoring of Face Transplant Recipients
C. Snopkowski¹, P. Rabbani², H. Yang¹, Z. Berman², G. Diep², C. Li¹, T. Muthukumar¹, R. Ding¹, D. Ceradini², M. Suthanthiran¹
¹Weill Cornell Medical Institute, Department of Medicine, Division of Nephrology, NY, NY, ²NYU Langone Health, Hansjörg Wyss Department of Plastic Surgery, NY, NY
*Purpose: Skin biopsies are currently the gold standard for evaluating the inflammatory status of face allografts. However, “tape stripping” is emerging as a noninvasive technique…